210 related articles for article (PubMed ID: 27661113)
21. Metformin and Risk of Malignant Brain Tumors in Patients with Type 2 Diabetes Mellitus.
Tseng CH
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439890
[TBL] [Abstract][Full Text] [Related]
22. Rosiglitazone has a null association with the risk of prostate cancer in type 2 diabetes patients.
Tseng CH
Front Endocrinol (Lausanne); 2023; 14():1185053. PubMed ID: 37560306
[TBL] [Abstract][Full Text] [Related]
23. Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus.
Tseng CH
Oncotarget; 2017 Jan; 8(2):3042-3048. PubMed ID: 27936468
[TBL] [Abstract][Full Text] [Related]
24. Metformin use is associated with a reduced risk of acute appendicitis in Taiwanese patients with type 2 diabetes mellitus.
Tseng CH
Sci Rep; 2021 Jun; 11(1):12400. PubMed ID: 34117321
[TBL] [Abstract][Full Text] [Related]
25. Metformin and risk of developing nasopharyngeal cancer in patients with type 2 diabetes mellitus.
Tseng CH
Metabolism; 2018 Aug; 85():223-226. PubMed ID: 29729227
[TBL] [Abstract][Full Text] [Related]
26. Metformin Use Is Associated With a Lower Risk of Hospitalization for Heart Failure in Patients With Type 2 Diabetes Mellitus: a Retrospective Cohort Analysis.
Tseng CH
J Am Heart Assoc; 2019 Nov; 8(21):e011640. PubMed ID: 31630591
[TBL] [Abstract][Full Text] [Related]
27. Metformin reduces risk of benign nodular goiter in patients with type 2 diabetes mellitus.
Tseng CH
Eur J Endocrinol; 2019 Jun; 180(6):365-372. PubMed ID: 30986765
[TBL] [Abstract][Full Text] [Related]
28. Metformin may reduce breast cancer risk in Taiwanese women with type 2 diabetes.
Tseng CH
Breast Cancer Res Treat; 2014 Jun; 145(3):785-90. PubMed ID: 24816805
[TBL] [Abstract][Full Text] [Related]
29. Pioglitazone and breast cancer risk in female patients with type 2 diabetes mellitus: a retrospective cohort analysis.
Tseng CH
BMC Cancer; 2022 May; 22(1):559. PubMed ID: 35585577
[TBL] [Abstract][Full Text] [Related]
30. Rosiglitazone may reduce thyroid cancer risk in patients with type 2 diabetes.
Tseng CH
Ann Med; 2013 Dec; 45(8):539-44. PubMed ID: 24215589
[TBL] [Abstract][Full Text] [Related]
31. Metformin and Risk of Hypertension in Taiwanese Patients With Type 2 Diabetes Mellitus.
Tseng CH
J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29954747
[TBL] [Abstract][Full Text] [Related]
32. Prolonged use of human insulin increases breast cancer risk in Taiwanese women with type 2 diabetes.
Tseng CH
BMC Cancer; 2015 Nov; 15():846. PubMed ID: 26537234
[TBL] [Abstract][Full Text] [Related]
33. Vildagliptin Has a Neutral Association With Dementia Risk in Type 2 Diabetes Patients.
Tseng CH
Front Endocrinol (Lausanne); 2021; 12():637392. PubMed ID: 33995274
[TBL] [Abstract][Full Text] [Related]
34. Metformin Is Associated with a Lower Incidence of Benign Brain Tumors: A Retrospective Cohort Study in Patients with Type 2 Diabetes Mellitus.
Tseng CH
Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680039
[No Abstract] [Full Text] [Related]
35. Sitagliptin use and risk of acute pancreatitis in type 2 diabetes mellitus: A population-based case-control study in Taiwan.
Liao KF; Lin CL; Lai SW; Chen WC
Eur J Intern Med; 2016 Jan; 27():76-9. PubMed ID: 26433909
[TBL] [Abstract][Full Text] [Related]
36. Metformin is associated with decreased skin cancer risk in Taiwanese patients with type 2 diabetes.
Tseng CH
J Am Acad Dermatol; 2018 Apr; 78(4):694-700. PubMed ID: 29246826
[TBL] [Abstract][Full Text] [Related]
37. Metformin and risk of chronic obstructive pulmonary disease in diabetes patients.
Tseng CH
Diabetes Metab; 2019 Apr; 45(2):184-190. PubMed ID: 29804817
[TBL] [Abstract][Full Text] [Related]
38. Metformin Use Is Associated with a Lower Risk of Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus.
Tseng CH
J Crohns Colitis; 2021 Jan; 15(1):64-73. PubMed ID: 32604412
[TBL] [Abstract][Full Text] [Related]
39. Metformin and the Risk of Dementia in Type 2 Diabetes Patients.
Chin-Hsiao T
Aging Dis; 2019 Feb; 10(1):37-48. PubMed ID: 30705766
[TBL] [Abstract][Full Text] [Related]
40. Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy.
Inzucchi SE; Tunceli K; Qiu Y; Rajpathak S; Brodovicz KG; Engel SS; Mavros P; Radican L; Brudi P; Li Z; Fan CP; Hanna B; Tang J; Blonde L
Diabetes Obes Metab; 2015 Oct; 17(10):956-64. PubMed ID: 25962401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
